Skip to main content

Articles

Page 24 of 77

  1. BACE1 and BACE2 belong to a class of proteases called β-secretases involved in ectodomain shedding of different transmembrane substrates. These enzymes have been extensively studied in Alzheimer's disease as t...

    Authors: Francesco Farris, Vittoria Matafora and Angela Bachi
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:147
  2. An amendment to this paper has been published and can be accessed via the original article.

    Authors: Juntao Sun, Tianyu Zhang, Mengmeng Cheng, Liwen Hong, Chen Zhang, Mengfan Xie, Peijun Sun, Rong Fan, Zhengting Wang, Lei Wang and Jie Zhong
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:145

    The original article was published in Journal of Experimental & Clinical Cancer Research 2019 38:104

  3. Tankyrase 1 (TNKS1) and tankyrase 2 (TNKS2) are two homologous proteins that are gaining increasing importance due to their implication in multiple pathways and diseases such as cancer. TNKS1/2 interact with a...

    Authors: Esteban Zamudio-Martinez, Ana Belén Herrera-Campos, Alberto Muñoz, José Manuel Rodríguez-Vargas and F. Javier Oliver
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:144
  4. Authors: Tingting Li, Qiuhua Lai, Shuyang Wang, Juanjuan Cai, Zhiyuan Xiao, Danling Deng, Liuqing He, Hongli Jiao, Yaping Ye, Li Liang, Yanqing Ding and Wenting Liao
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:143

    The original article was published in Journal of Experimental & Clinical Cancer Research 2016 35:21

  5. Breast cancer is a heterogeneous disease with a complex microenvironment consisting of tumor cells, immune cells, fibroblasts and vascular cells. These cancer-associated cells shape the tumor microenvironment ...

    Authors: Xueqi Yan, Yinghong Xie, Fan Yang, Yijia Hua, Tianyu Zeng, Chunxiao Sun, Mengzhu Yang, Xiang Huang, Hao Wu, Ziyi Fu, Wei Li, Shiping Jiao and Yongmei Yin
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:142
  6. Retinoids are promising agents in the treatment of different types of neoplasia including estrogen receptor-positive breast cancers, whereas refractoriness/low sensitivity is observed in triple-negative breast...

    Authors: Siyue Lou, Hang Gao, Huanwu Hong, Zhihui Zhu and Huajun Zhao
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:141
  7. The conventional method used to obtain a tumor biopsy for hepatocellular carcinoma (HCC) is invasive and does not evaluate dynamic cancer progression or assess tumor heterogeneity. It is thus imperative to cre...

    Authors: Yan Li, Yuanyuan Zheng, Liwei Wu, Jingjing Li, Jie Ji, Qiang Yu, Weiqi Dai, Jiao Feng, Jianye Wu and Chuanyong Guo
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:140

    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2021 40:229

  8. Glioblastomas stem-like cells (GSCs) by invading the brain parenchyma, remains after resection and radiotherapy and the tumoral microenvironment become stiffer. GSC invasion is reported as stiffness sensitive ...

    Authors: Emilie Marhuenda, Christine Fabre, Cunjie Zhang, Martà Martin-Fernandez, Thomas Iskratsch, Ali Saleh, Luc Bauchet, Julien Cambedouzou, Jean-Philippe Hugnot, Hugues Duffau, James W. Dennis, David Cornu and Norbert Bakalara
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:139
  9. Pemetrexed (MTA) plus cisplatin combination therapy is considered the standard of care for patients with advanced non-small-cell lung cancer (NSCLC). However, in advanced NSCLC, the 5-year survival rate is bel...

    Authors: Yanyun Gao, Philipp Zens, Min Su, Camila Anna Gemperli, Haitang Yang, Haibin Deng, Zhang Yang, Duo Xu, Sean R. R. Hall, Sabina Berezowska, Patrick Dorn, Ren-Wang Peng, Ralph Alexander Schmid, Wenxiang Wang and Thomas Michael Marti
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:138
  10. An amendment to this paper has been published and can be accessed via the original article.

    Authors: Yan Chen, Zhonghu Li, Mengyun Zhang, Bo Wang, Jiaxin Ye, Yang Zhang, Di Tang, Dandan Ma, Weidong Jin, Xiaowu Li and Shuguang Wang
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:137

    The original article was published in Journal of Experimental & Clinical Cancer Research 2019 38:466

  11. Oxidative stress is a hallmark of many cancers. The increment in reactive oxygen species (ROS), resulting from an increased mitochondrial respiration, is the major cause of oxidative stress. Cell fate is known...

    Authors: Giovanna Carrà, Giuseppe Ermondi, Chiara Riganti, Luisella Righi, Giulia Caron, Alessio Menga, Enrica Capelletto, Beatrice Maffeo, Marcello Francesco Lingua, Federica Fusella, Marco Volante, Riccardo Taulli, Angelo Guerrasio, Silvia Novello, Mara Brancaccio, Rocco Piazza…
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:136
  12. An amendment to this paper has been published and can be accessed via the original article.

    Authors: Kai Teng, Shi Wei, Chi Zhang, Jiewei Chen, Jinbin Chen, Kanghua Xiao, Jun Liu, Miaomiao Dai, Xinyuan Guan, Jingping Yun and Dan Xie
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:135

    The original article was published in Journal of Experimental & Clinical Cancer Research 2019 38:329

  13. Glioma is the most common and malignant tumor of central nervous system. The tumor initiation, self-renewal, and multi-lineage differentiation abilities of glioma stem cells (GSCs) are responsible for glioma p...

    Authors: Junshuang Zhao, Yang Jiang, Haiying Zhang, Jinpeng Zhou, Lian Chen, Hao Li, Jinkun Xu, Guoqing Zhang and Zhitao Jing
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:134
  14. Pancreatic stellate cells (PSCs) occupy the majority of the pancreatic cancer microenvironment, contributing to aggressive behavior of pancreatic cancer cells (PCCs). Recently, anti-fibrotic agents have proven...

    Authors: Haimin Feng, Taiki Moriyama, Kenoki Ohuchida, Nan Sheng, Chika Iwamoto, Koji Shindo, Kengo Shirahane, Naoki Ikenaga, Shuntaro Nagai, Kohei Nakata, Kazuhiro Mizumoto and Masafumi Nakamura
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:133
  15. Cancer stem cell (CSC)-related chemoresistance leads to poor outcome of the patients with colorectal cancer (CRC). In this study, we identified the chemoresistance-relevant molecules and decipher the involved ...

    Authors: Xiaofeng Liu, Kunqi Su, Xiaoyan Sun, Yang Jiang, Lijun Wang, Chenyu Hu, Chunfeng Zhang, Min Lu, Xiaojuan Du and Baocai Xing
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:132
  16. Hypoxia, a condition of oxygen deprivation, is considered a hallmark of tumor microenvironment regulating several pathways and promoting cancer progression and resistance to therapy. Semaphorins, a family of a...

    Authors: Elisabetta Valentini, Marta Di Martile, Donatella Del Bufalo and Simona D’Aguanno
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:131
  17. An amendment to this paper has been published and can be accessed via the original article.

    Authors: KanKan Yang, LinHua Jiang, You Hu, Jing Yu, HenFeng Chen, YiZhou Yao and XinGuo Zhu
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:130

    The original article was published in Journal of Experimental & Clinical Cancer Research 2015 34:40

  18. Innovative therapies to target tumor-associated neutrophils (PMN) are of clinical interest, since these cells are centrally involved in cancer inflammation and tumor progression. Resolvin D1 (RvD1) is a lipid ...

    Authors: Domenico Mattoscio, Elisa Isopi, Alessia Lamolinara, Sara Patruno, Alessandro Medda, Federica De Cecco, Susanna Chiocca, Manuela Iezzi, Mario Romano and Antonio Recchiuti
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:129
  19. An amendment to this paper has been published and can be accessed via the original article.

    Authors: Qian Chen, Xiao-Wei Zhou, Ai-Jun Zhang and Kang He
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:128

    The original article was published in Journal of Experimental & Clinical Cancer Research 2021 40:23

  20. Hepatocellular carcinoma (HCC) is one of the most common malignant cancers worldwide, and liver cancer has increased in mortality due to liver cancer because it was detected at an advanced stages in patients w...

    Authors: Sanghwa Kim, Minji Lee, Yeonhwa Song, Su-Yeon Lee, Inhee Choi, I-Seul Park, Jiho Kim, Jin-sun Kim, Kang mo Kim and Haeng Ran Seo
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:127
  21. NOD-like receptors affect multiple stages of cancer progression in many malignancies. NACHT, LRR, and PYD domain-containing protein 7 (NLRP7) is a member of the NOD-like receptor family, although its role in t...

    Authors: Bing Li, Zhi-Peng Qi, Dong-Li He, Zhang-Han Chen, Jing-Yi Liu, Meng-Wai Wong, Jia-Wei Zhang, En-Pan Xu, Qiang Shi, Shi-Lun Cai, Di Sun, Li-Qing Yao, Ping-Hong Zhou and Yun-Shi Zhong
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:126
  22. Dehydrodiisoeugenol (DEH), a novel lignan component extracted from nutmeg, which is the seed of Myristica fragrans Houtt, displays noticeable anti-inflammatory and anti-allergic effects in digestive system diseas...

    Authors: Changhong Li, Kui Zhang, Guangzhao Pan, Haoyan Ji, Chongyang Li, Xiaowen Wang, Xin Hu, Ruochen Liu, Longfei Deng, Yi Wang, Liqun Yang and Hongjuan Cui
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:125

    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2023 42:153

  23. Pancreatic cancer is a malignant tumor and ranks the sixth in incidence among cancers. Circular RNA (circRNA) has been reported to regulate the progression of pancreatic cancer. However, the effects of circ-me...

    Authors: Xiaoxiao Zhou, Kun Liu, Jing Cui, Jiongxin Xiong, Heshui Wu, Tao Peng and Yao Guo
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:124
  24. Long noncoding RNAs (lncRNAs) contribute to multiple biological processes in human glioblastoma (GBM). However, identifying a specific lncRNA target remains a challenge. In this study, bioinformatics methods a...

    Authors: Chen Zhong, Qian Yu, Yucong Peng, Shengjun Zhou, Zhendong Liu, Yong Deng, Leiguang Guo, Shiguang Zhao and Gao Chen
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:123
  25. PARP inhibitors (PARPi) benefit only a fraction of breast cancer patients with BRCA mutations, and their efficacy is even more limited in triple-negative breast cancer (TNBC) due to clinical primary and acquir...

    Authors: Xiuzhi Zhu, Li Chen, Binhao Huang, Xiaoguang Li, Liu Yang, Xin Hu, Yizhou Jiang, Zhimin Shao and Zhonghua Wang
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:122
  26. Reprogrammed glucose metabolism, also known as the Warburg effect, which is essential for tumor progression, is regarded as a hallmark of cancer. MAP17, a small 17-kDa non-glycosylated membrane protein, is fre...

    Authors: Fangyuan Dong, Rongkun Li, Jiaofeng Wang, Yan Zhang, Jianfeng Yao, Shu-Heng Jiang, Xiaona Hu, Mingxuan Feng and Zhijun Bao
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:121
  27. Not all breast cancer (BC) patients who receive neoadjuvant chemotherapy achieve a pathologic complete response (pCR), but the reasons for this are unknown. Previous studies have shown that exosomes produced i...

    Authors: Qianxi Yang, Shaorong Zhao, Zhendong Shi, Lixia Cao, Jingjing Liu, Teng Pan, Dongdong Zhou and Jin Zhang
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:120
  28. The circadian system temporally regulates physiology to maintain homeostasis. Co-opting and disrupting circadian signals appear to be distinct attributes that are functionally important for the development of ...

    Authors: Elizabeth Cash, Sandra Sephton, Cassandra Woolley, Attia M. Elbehi, Anu R. I., Bene Ekine-Afolabi and Victor C. Kok
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:119
  29. Hepatoma is a common malignancy of the liver. The abnormal high expression of alpha-fetoprotein (AFP) is intimately associated with hepatoma progress, but the mechanism of transcriptional regulation and singul...

    Authors: Zhengyi Cao, Yuning Cheng, Jiyin Wang, Yujuan Liu, Ruixiang Yang, Wei Jiang, Hui Li and Xiaowei Zhang
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:118
  30. The application of immune-based therapies has revolutionized cancer treatment. Yet how the immune system responds to phenotypically heterogeneous populations within tumors is poorly understood. In melanoma, on...

    Authors: Luis Sánchez-del-Campo, Román Martí-Díaz, María F. Montenegro, Rebeca González-Guerrero, Trinidad Hernández-Caselles, Enrique Martínez-Barba, Antonio Piñero-Madrona, Juan Cabezas-Herrera, Colin R. Goding and José Neptuno Rodríguez-López
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:117
  31. High grade serous ovarian cancer (HGSOC) is among the deadliest human cancers and its prognosis remains extremely poor. Tumor heterogeneity and rapid acquisition of resistance to conventional chemotherapeutic ...

    Authors: Camilla Nero, Giuseppe Vizzielli, Domenica Lorusso, Eleonora Cesari, Gennaro Daniele, Matteo Loverro, Giovanni Scambia and Claudio Sette
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:116
  32. An amendment to this paper has been published and can be accessed via the original article.

    Authors: Gangjun Yuan, Xin Chen, Zhuowei Liu, Wensu Wei, Qinghai Shu, Hussein Abou-Hamdan, Lijuan Jiang, Xiangdong Li, Rixin Chen, Laurent Désaubry, Fangjian Zhou and Dan Xie
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:115

    The original article was published in Journal of Experimental & Clinical Cancer Research 2018 37:21

  33. Colorectal cancer (CRC) is a clinically challenging malignant tumor worldwide. As a natural product and sesquiterpene lactone, Costunolide (CTD) has been reported to possess anticancer activities. However, the...

    Authors: Hai Huang, Song Park, Haibo Zhang, Sijun Park, Wookbong Kwon, Enugyung Kim, Xiujuan Zhang, Soyoung Jang, Duhak Yoon, Seong-Kyoon Choi, Jun-koo Yi, Sung-hyun Kim, Zigang Dong, Mee-hyun Lee, Zaeyoung Ryoo and Myoung Ok Kim
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:114
  34. Elafin is a serine protease inhibitor critical for host defence. We previously reported that Elafin was associated with the recurrence of early-stage hepatocellular carcinoma (HCC) after surgery. However, the ...

    Authors: Chenwei Wang, Yadi Liao, Wei He, Hong Zhang, Dinglan Zuo, Wenwu Liu, Zhiwen Yang, Jiliang Qiu, Yichuan Yuan, Kai Li, Yuanping Zhang, Yongjin Wang, Yunxing Shi, Yuxiong Qiu, Song Gao, Yunfei Yuan…
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:113

    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2022 41:104

  35. MicroRNAs (miRNAs) regulate the expression of their target genes post-transcriptionally; thus, they are deeply involved in fundamental biological processes. miRNA clusters contain two or more miRNA-encoding ge...

    Authors: Kosuke Yoshida, Akira Yokoi, Yusuke Yamamoto and Hiroaki Kajiyama
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:112
  36. An amendment to this paper has been published and can be accessed via the original article.

    Authors: Yuhui Zhang, Weibin Huang, Yujie Yuan, Jin Li, Jing Wu, Jie Yu, Yulong He, Zhewei Wei and Changhua Zhang
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:111

    The original article was published in Journal of Experimental & Clinical Cancer Research 2020 39:141

  37. Multiple myeloma (MM) is an incurable disease. The acquisition of resistance to drugs, including immunomodulatory drugs (IMiDs), has a negative effect on its prognosis. Cereblon (CRBN) is a key mediator of the...

    Authors: Mitsuhito Hirano, Yoichi Imai, Yuta Kaito, Takahiko Murayama, Kota Sato, Tadao Ishida, Junichi Yamamoto, Takumi Ito, Muneyoshi Futami, Masaki Ri, Hiroshi Yasui, Tamami Denda, Yukihisa Tanaka, Yasunori Ota, Masanori Nojima, Yasuhiko Kamikubo…
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:110
  38. Distant metastasis is the leading cause of death for esophageal squamous cell carcinoma (ESCC) with limited treatment options and unsatisfactory effectiveness. Bromodomain (BRD) containing proteins are emergin...

    Authors: Lian-Jing Cao, Yi-Jun Zhang, Si-Qi Dong, Xi-Zhao Li, Xia-Ting Tong, Dong Chen, Zi-Yi Wu, Xiao-Hui Zheng, Wen-Qiong Xue, Wei-Hua Jia and Jiang-Bo Zhang
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:109
  39. An amendment to this paper has been published and can be accessed via the original article.

    Authors: Weiqiang Huang, Longshan Zhang, Mi Yang, Xixi Wu, Xiaoqing Wang, Wenqi Huang, Lu Yuan, Hua Pan, Yin Wang, Zici Wang, Yuting Wu, Jihong Huang, Huazhen Liang, Shaoqun Li, Liwei Liao, Laiyu Liu…
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:108

    The original article was published in Journal of Experimental & Clinical Cancer Research 2021 40:87

  40. Cancer-secreted exosomal miRNAs regulates the biological processes of many tumours. The serum level of exosomal miR-106b-5p is significantly increased in melanoma patients. However, the role and molecular mech...

    Authors: Wenkang Luan, Yuting Ding, Haolan Xi, Hongru Ruan, Feng Lu, Shaojun Ma and Jinlong Wang
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:107
  41. Although the anti-HER2 antibody trastuzumab augments patient survival in HER2+ breast cancer, a relevant number of patients progress to this treatment. In this context, novel drug combinations are needed to in...

    Authors: María del Mar Noblejas-López, Cristina Nieto-Jiménez, Eva M. Galán-Moya, David Tebar-García, Juan Carlos Montero, Atanasio Pandiella, Miguel Burgos and Alberto Ocaña
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:106
  42. Esophageal squamous cell carcinoma (ESCC) is an aggressive and lethal cancer with a low 5 year survival rate. Identification of new therapeutic targets and its inhibitors remain essential for ESCC prevention a...

    Authors: Xuechao Jia, Chuntian Huang, Yamei Hu, Qiong Wu, Fangfang Liu, Wenna Nie, Hanyong Chen, Xiang Li, Zigang Dong and Kangdong Liu
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:105
  43. An amendment to this paper has been published and can be accessed via the original article.

    Authors: Xingrong Zheng, Jiaxin Lin, Hewei Wu, Zhishuo Mo, Yunwen Lian, Peipei Wang, Zhaoxia Hu, Zhiliang Gao, Liang Peng and Chan Xie
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:104

    The original article was published in Journal of Experimental & Clinical Cancer Research 2019 38:475

  44. Circular RNAs (circRNAs) have emerged as a new subclass of regulatory RNAs that play critical roles in various cancers. Cancer stem cells (CSCs), a small subset of cancer cells, are believed to possess the cap...

    Authors: Yiwen Xia, Jialun Lv, Tianlu Jiang, Bowen Li, Ying Li, Zhongyuan He, Zhe Xuan, Guangli Sun, Sen Wang, Zheng Li, Weizhi Wang, Linjun Wang and Zekuan Xu
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:103
  45. Deciphering extracellular matrix (ECM) composition and architecture may represent a novel approach to identify diagnostic and therapeutic targets in cancer. Among the ECM components, fibronectin and its fibril...

    Authors: Sheila Spada, Annalisa Tocci, Francesca Di Modugno and Paola Nisticò
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:102
  46. Metastasis is the key cause of death in ovarian cancer patients. To figure out the biological nature of cancer metastasis is essential for developing effective targeted therapy. Here we investigate how long no...

    Authors: Conghui Wang, Jiaying Wang, Xiameng Shen, Mingyue Li, Yongfang Yue, Xiaodong Cheng, Weiguo Lu, Xinyu Wang and Xing Xie
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:101
  47. Multiple myeloma (MM) cell motility is a critical step during MM dissemination throughout the body, but how it is regulated remains largely unknown. As hypercalcemia is an important clinical feature of MM, hig...

    Authors: Parinya Samart, Sudjit Luanpitpong, Yon Rojanasakul and Surapol Issaragrisil
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:100
  48. Due to the hypoxia and nutrient deficiency microenvironment, glioblastoma (GBM) exhibits high autophagy activity and autophagy plays an important role in the progression of GBM. However, the molecular mechanis...

    Authors: Min Zhao, Yu Zhang, Yang Jiang, Kai Wang, Xiang Wang, Ding Zhou, Yan Wang, Rutong Yu and Xiuping Zhou
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:99
  49. Bone metastasis is the leading cause of mortality and reduced quality of life in patients with metastatic prostate cancer (PCa). Long non-coding RNA activated by DNA damage (NORAD) has been observed to have an...

    Authors: Chuan-yi Hu, Juan Chen, Xin-hua Qin, Pan You, Jie Ma, Jing Zhang, He Zhang and Ji-dong Xu
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:98
  50. Cancer occurs in a complex tissue environment, and its progression depends largely on the tumour microenvironment (TME). The TME has a highly complex and comprehensive system accompanied by dynamic changes and...

    Authors: Haoze Li, Lihong Zhou, Jing Zhou, Qi Li and Qing Ji
    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:97

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 11.4
    5-year Journal Impact Factor: 11.4
    Source Normalized Impact per Paper (SNIP): 1.770
    SCImago Journal Rank (SJR): 2.806

    Speed 2023
    Submission to first editorial decision (median days): 5
    Submission to acceptance (median days): 100

    Usage 2023
    Downloads: 3,003,080
    Altmetric mentions: 3,022